ArticleJournal of hematology2025

Ruxolitinib Is an Effective Therapy for Ciltacabtagene Autoleucel-Associated Parkinsonism in Multiple Myeloma.

Baldeep Wirk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.